AYEM:F:F-iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.468

Change

+0.13 (+1.97)%

Market Cap

USD 3.13B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.10%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.60 (+0.25%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.28 (+0.28%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.24 (+0.24%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

-3.78 (-2.48%)

USD 37.92B

ETFs Containing AYEM:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.31% 81% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.31% 78% C+ 64% D
Trailing 12 Months  
Capital Gain 21.33% 65% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.33% 61% D- 56% F
Trailing 5 Years  
Capital Gain 36.10% 55% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.10% 55% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 5.30% N/A N/A 59% D-
Dividend Return 5.30% N/A N/A 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.33% N/A N/A 76% C+
Risk Adjusted Return 34.58% N/A N/A 58% F
Market Capitalization 3.13B 89% A- 72% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike